复兴旧抗生素:新征兆和治疗前景 - - 综述
Paweł Radkowski1,2,3, Julia Oszytko4, Kamil Sobolewski2
1Department of Anaesthesiology and Intensive Care, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
Pharmaceuticals (Basel, Switzerland)
|February 27, 2026
概括
重新利用老旧的抗生素,如菌素和胆固醇素,提供了对抗日益增长的抗菌素耐药性 (AMR) 的重要策略. 药物输送和剂量的进步使这些遗留药物优化,用于治疗多抗药性感染.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益严重的全球健康危机,降低了现代抗生素的疗效.
- 以前因毒性或药理动力学问题而被排除在外的较旧的抗微生物药物正在重新评估.
- 药物输送和剂量策略的进步重新引起了对这些遗留的抗生素的兴趣.
研究的目的:
- 进行对精选的旧抗生素进行比较,临床重点审查:氏素,氏素,氏素和氏素.
- 分析它们当前的治疗作用,药理动力学/药理动力学 (PK/PD) 目标和耐药性机制.
- 探索减轻毒性和提高疗效的策略,包括组合疗法和替代药物管理途径.
主要方法:
- 采用了一个叙事审查方法.
- 搜索使用PubMed进行,并使用手动参考选.
- 专注于临床,PK/PD和转化研究,这些研究与当代使用传统抗生素相关.
主要成果:
- 该评论总结了关于色胺素,胆固醇素,链状胺素和色胺素重新出现的临床应用的当前证据.
- 对每种药物的历史使用,作用机制,耐药性模式和新指示进行了讨论.
- 新型配方,组合策略和替代的注射途径被强调为提高疗效和降低毒性,包括对生物膜感染.
结论:
- 旧抗生素的战略改用是一种有价值的补充方法,可以对抗AMR.
- 这些遗留的药物可以优化用于治疗多抗药性感染,延长它们的治疗寿命.
- 这一战略在抗生素创新有限的时代至关重要.
相关概念视频
01:27Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
00:57Antibiotic Selection
61.0K
Overview
61.0K
01:30Development of Antibiotic Resistance
1.7K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
232
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
232
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.6K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.6K